Phase 2 Allergic Clinical Trials
23 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–20 of 23 trials
Recruiting
Phase 2
Phase 2 Study of Lesigercept in Adult Patients With Chronic Spontaneous Urticaria Who Are Inadequately Controlled by H1-Antihistamines
Chronic Spontaneous Urticaria (CSU)Allergic Diseases
Yuhan Corporation150 enrolled30 locationsNCT07415551
Recruiting
Phase 2
Clinical Study on TQH2722 Injection Combined With Background Therapy for Seasonal Allergic Rhinitis
Seasonal Allergic Rhinitis
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.300 enrolled30 locationsNCT07398859
Recruiting
Phase 1Phase 2
Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without Asthma
Allergic AsthmaAllergic Rhinitis
University of Zurich36 enrolled1 locationNCT06960382
Recruiting
Phase 2
Dupilumab Effects Against Aeroallergen Challenge
Asthma, Allergic
The University of Texas Health Science Center at San Antonio88 enrolled2 locationsNCT05720325
Recruiting
Phase 2
5HTP Regulation Of Asthma In Children
Mild or Moderate Asthma With Allergic Sensitization
Indiana University20 enrolled1 locationNCT04160910
Recruiting
Phase 2
Evaluate the Efficacy and Safety of FB825 in Adult With Allergic Asthma
Allergic Asthma
Oneness Biotech Co., Ltd.100 enrolled13 locationsNCT05008965
Recruiting
Phase 2
Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients
Allergic Asthma
Longbio Pharma200 enrolled1 locationNCT07342803
Not Yet Recruiting
Phase 2
A Phase 2 Randomised Double-Blind Placebo-Controlled Trial of Topical Intranasal Botulinum Toxin Type A for the Treatment of Refractory Rhinitis
Refractory Allergic SinusitisRefractory Non-Allergic Rhinitis
Metro North Hospital and Health Services100 enrolled1 locationACTRN12625001411437
Recruiting
Phase 2Phase 3
Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation
Skin InflammationAllergic Contact Dermatitis
Wei-Che Ko45 enrolled1 locationNCT05535738
Recruiting
Phase 2
A Study to Determine the Optimal Dose and Frequency of ALDP001 Nasal Spray in Adults With Seasonal Allergic Rhinitis Under Allergen Exposure
Seasonal Allergic Rhinitis (SAR)
Alixer Nexgen Therapeutics Limited164 enrolled1 locationNCT07219849
Recruiting
Phase 2
Study of CM310 in Patients With Uncontrolled Seasonal Allergic Rhinitis
Seasonal Allergic Rhinitis
Beijing Tongren Hospital120 enrolled1 locationNCT06300203
Recruiting
Phase 2
A Clinical Study on the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis
Seasonal Allergic Rhinitis
Guangdong Hengrui Pharmaceutical Co., Ltd100 enrolled1 locationNCT07091357
Recruiting
Phase 2
Efficacy of Placebo Versus Chlorpheniramine for the Prevention of Allergic Transfusion Reactions.
Allergic Transfusion Reaction
Institute of Hematology & Blood Diseases Hospital, China6,642 enrolled4 locationsNCT04688736
Recruiting
Phase 2
iMagIng pulmonaRy Aspergillosis Using Gallium-68-dEferoxamine
Allergic Bronchopulmonary AspergillosisChronic Pulmonary AspergillosisPulmonary Aspergillosis
Radboud University Medical Center10 enrolled1 locationNCT06244979
Recruiting
Phase 2Phase 3
Phase II/III Seamless Clinical Study of MG-K10 Humanized Monoclonal Antibody Injection in Treatment of Seasonal Allergic Rhinitis
Seasonal Allergic Rhinitis
Shanghai Mabgeek Biotech.Co.Ltd160 enrolled1 locationNCT06846385
Recruiting
Phase 2
Viral Mucosal Reprogramming
AsthmaHealthyAllergic Rhinitis+1 more
The University of Texas Medical Branch, Galveston75 enrolled1 locationNCT05331170
Recruiting
Phase 2
Study of Stapokibart Injection in Patients With Allergic Rhinitis
Allergic Rhinitis
Keymed Biosciences Co.Ltd120 enrolled1 locationNCT06525597
Recruiting
Phase 2Phase 3
Intralymphatic Immunotherapy Enhanced by Vitamin-D, a Randomized Placebo-controlled Trial and Comparison With SLIT
Allergic Rhinitis Due to Grass Pollen
Lars Olaf Cardell360 enrolled3 locationsNCT06061848
Completed
Phase 2Phase 3
Omalizumab for Chronic Allergic Bronchopulmonary Aspergillosis: a randomised, placebo-controlled crossover trial
Allergic Bronchopulmonary Aspergillosis
Jo Douglass14 enrolled1 locationACTRN12613000278730
Completed
Phase 2
Study to compare the effects of taking 2.5mg of the antihstamine, Loratidine, four times a day with taking 10mg of Loratidine once a day in healthy volunteers
Allergic rhinitis and relief of other allergic symptoms
AFT Pharmaceuticals Ltd25 enrolled2 locationsACTRN12609000702213